![]() |
市场调查报告书
商品编码
1856937
全球医疗设备连接市场:预测至 2032 年-按组件、部署方式、技术、应用、最终用户和地区进行分析Medical Device Connectivity Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software, Services), Deployment Mode, Technology, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2025 年,全球医疗设备连接市场规模将达到 34 亿美元,到 2032 年将达到 121 亿美元,预测期内复合年增长率为 20.1%。
医疗设备互联是指医疗设备与医疗保健IT系统之间的整合和通讯,从而实现无缝资料交换和即时监测。这项技术使患者监护仪、输液帮浦和人工呼吸器等设备能够将关键资讯直接传输到电子健康记录(EHR)系统,从而改善临床工作流程和患者预后。透过自动化资料收集和减少人工输入,它提高了医疗保健环境中的准确性、效率和决策能力。医疗设备互联支援远端监测、远端医疗和跨平台互通性,使其成为现代数据主导医疗保健环境中至关重要的组成部分,该环境强调安全性、品质和卓越营运。
扩大电子健康记录(EHR)的使用
电子健康记录(EHR) 的日益普及是医疗设备互联市场的主要驱动力。 EHR 系统需要与医疗设备无缝集成,以确保准确的即时数据收集并改善临床工作流程。互联功能可以增强患者监测、减少人为错误并支援更快的决策。随着医疗服务提供者优先考虑数位转型和数据互通性,对能够直接与 EHR 平台连接的互联设备的需求不断增长,从而推动了全球市场的扩张。
高昂的实施成本
高昂的实施成本仍是医疗设备互联市场的主要限制因素。将设备整合到IT系统中需要对硬体、软体和专业人员进行大量投资。规模较小的医疗机构可能面临预算限制,难以采用先进的互联解决方案。此外,持续的维护和升级也会加重财务负担。这些成本相关的挑战会减缓市场渗透速度,尤其是在医疗技术基础设施和资金有限的发展中地区。
技术进步
科技进步为医疗设备互联市场的发展提供了巨大的机会。无线通讯、云端运算和互通性标准的创新,使得设备整合更有效率且可扩展。物联网和人工智慧等新技术增强了远端监控和预测分析能力,从而改善了患者的治疗效果。随着医疗保健系统的现代化,对智慧连网型设备的需求日益增长。这些进步实现了无缝数据交换,减少了人工干预,并支持个人化护理,从而促进了市场在各种医疗保健环境中的扩张。
资料安全和隐私问题
资料安全和隐私问题严重阻碍了医疗设备互联市场的成长。互联设备间传输敏感的患者资料会增加网路攻击和资料外洩的风险,从而导致潜在的法律责任和信任危机。由于需要遵守 HIPAA 和 GDPR 等法规,医疗服务提供者可能对采用互联解决方案犹豫不决。这些顾虑会延缓整合进程,并增加互联繫统安全保障的成本和复杂性。
新冠疫情显着加速了医疗设备互联技术的应用。随着远端患者监护和远端医疗服务的普及,医疗机构越来越依赖连网设备在传统诊疗环境之外进行诊疗工作。此次疫情凸显了即时数据交换和互通性的重要性,并刺激了对数位基础设施的投资。儘管供应链中断初期影响了设备的可得性,但从长远来看,其影响是积极的,提高了人们对互联解决方案的认知和需求,从而推动了创新和市场成长。
预计在预测期内,输液帮浦细分市场将成为最大的细分市场。
由于输液帮浦在医院和诊所中被广泛用于精准给药,预计在预测期内,输液帮浦细分市场将占据最大的市场份额。这些设备需要可靠的连接,以确保准确的剂量追踪并与电子病历系统整合。随着慢性病管理和住院治疗需求的不断增长,输液帮浦在提高治疗效率和安全性方面发挥着至关重要的作用。它们与各种连接平台的兼容性使其成为现代医疗工作流程的基石。
预计在预测期内,麻醉仪器细分市场将实现最高的复合年增长率。
由于手术量的增加和对先进监测技术的需求,麻醉仪器领域预计将在预测期内实现最高成长率。互联技术能够将麻醉仪器的即时资料传输至电子病历系统 (EHR),从而提升病患安全和临床决策水准。机器设计和整合能力的创新使这些设备更能适应互联环境。随着医院在手术室中日益重视精准性和自动化,连网麻醉仪器的应用预计将迅速成长。
预计亚太地区将在预测期内占据最大的市场份额,这主要得益于快速的都市化、不断扩大的医疗基础设施以及对数位医疗技术日益增长的投资。中国、印度和日本等国家正在采用互联医疗解决方案,以改善患者疗效并提高营运效率。政府支持医疗资讯技术应用的倡议以及领先医疗设备製造商的存在,进一步巩固了该地区在全球市场的主导地位。
预计北美在预测期内将实现最高的复合年增长率。这主要得益于该地区先进的医疗基础设施、健全的法规结构以及电子病历(EHR)系统的高普及率,这些因素共同推动了北美地区的快速成长。对病患安全、资料互通性和远端监控的日益重视,也推动了对连网型设备的需求。此外,主要市场参与者的存在以及持续的技术创新,使北美成为医疗保健领域尖端互联解决方案的中心。
According to Stratistics MRC, the Global Medical Device Connectivity Market is accounted for $3.4 billion in 2025 and is expected to reach $12.1 billion by 2032 growing at a CAGR of 20.1% during the forecast period. Medical Device Connectivity refers to the integration and communication of medical devices with healthcare IT systems, enabling seamless data exchange and real-time monitoring. This technology allows devices such as patient monitors, infusion pumps, and ventilators to transmit vital information directly to electronic health records (EHRs), improving clinical workflows and patient outcomes. By automating data capture and reducing manual entry, it enhances accuracy, efficiency, and decision-making in healthcare settings. Medical device connectivity supports remote monitoring, telehealth, and interoperability across platforms, making it a critical component in modern, data-driven healthcare environments focused on safety, quality, and operational excellence.
Growing Adoption of Electronic Health Records (EHRs)
The increasing adoption of Electronic Health Records (EHRs) is a major driver of the medical device connectivity market. EHR systems require seamless integration with medical devices to ensure accurate, real-time data capture and improved clinical workflows. Connectivity enhances patient monitoring, reduces manual errors, and supports faster decision-making. As healthcare providers prioritize digital transformation and data interoperability, the demand for connected devices that can interface directly with EHR platforms continues to rise, fueling market expansion globally.
High Implementation Costs
High implementation costs remain a significant restraint in the medical device connectivity market. Integrating devices with IT systems involves substantial investment in hardware, software, and skilled personnel. Smaller healthcare facilities may struggle with budget constraints, limiting their ability to adopt advanced connectivity solutions. Additionally, ongoing maintenance and upgrades add to the financial burden. These cost-related challenges can slow market penetration, especially in developing regions where infrastructure and funding for healthcare technology are limited.
Technological Advancements
Technological advancements present a strong opportunity for growth in the medical device connectivity market. Innovations in wireless communication, cloud computing, and interoperability standards are making device integration more efficient and scalable. Emerging technologies like IoT and AI enhance remote monitoring and predictive analytics, improving patient outcomes. As healthcare systems modernize, the demand for smart, connected devices grows. These advancements enable seamless data exchange, reduce manual intervention, and support personalized care, driving market expansion across diverse medical settings.
Data Security and Privacy Concerns
Data security and privacy concerns significantly hinder the growth of the medical device connectivity market. The transmission of sensitive patient data across connected devices raises risks of cyberattacks and data breaches, leading to potential legal liabilities and loss of trust. Healthcare providers may hesitate to adopt connectivity solutions due to compliance challenges with regulations like HIPAA and GDPR. These concerns slow integration efforts and increase the cost and complexity of securing connected systems.
The COVID-19 pandemic significantly accelerated the adoption of medical device connectivity. With the surge in remote patient monitoring and telehealth services, healthcare providers relied heavily on connected devices to manage care outside traditional settings. The crisis highlighted the importance of real-time data exchange and interoperability, prompting investments in digital infrastructure. While supply chain disruptions initially affected device availability, the long-term impact has been positive, with increased awareness and demand for connectivity solutions driving innovation and market growth.
The infusion pumps segment is expected to be the largest during the forecast period
The infusion pumps segment is expected to account for the largest market share during the forecast period, owing to its widespread use in hospitals and clinics for precise drug delivery. These devices require reliable connectivity to ensure accurate dosage tracking and integration with EHR systems. As chronic disease management and inpatient care demand grow, infusion pumps play a critical role in improving treatment efficiency and safety. Their compatibility with connectivity platforms makes them a cornerstone of modern healthcare workflows.
The anesthesia machines segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the anesthesia machines segment is predicted to witness the highest growth rate, due to increasing surgical procedures and demand for advanced monitoring. Connectivity enables real-time data transmission from anesthesia machines to EHRs, enhancing patient safety and clinical decision-making. Innovations in machine design and integration capabilities are making these devices more adaptable to connected environments. As hospitals prioritize precision and automation in operating rooms, the adoption of connected anesthesia machines is expected to surge rapidly.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, because rapid urbanization, expanding healthcare infrastructure, and growing investments in digital health technologies are driving demand. Countries like China, India, and Japan are embracing connected healthcare solutions to improve patient outcomes and operational efficiency. Government initiatives supporting health IT adoption and the presence of major medical device manufacturers further strengthen the region's dominant position in the global market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, because region's advanced healthcare infrastructure, strong regulatory framework, and high adoption of EHR systems contribute to rapid growth. Increasing focus on patient safety, data interoperability, and remote monitoring fuel demand for connected devices. Additionally, the presence of key market players and ongoing technological innovation make North America a hub for cutting-edge connectivity solutions in healthcare.
Key players in the market
Some of the key players in Medical Device Connectivity Market include Medtronic, Johnson & Johnson, Stryker Corporation, Abbott Laboratories, Boston Scientific, GE Healthcare, Philips Healthcare, Siemens Healthineers, Becton, Dickinson and Company (BD), Masimo Corporation, Hillrom (Baxter International), Cerner Corporation, Capsule Technologies, Smiths Medical, Nihon Kohden
In March 2025, Cadrenal Therapeutics has partnered with Abbott to advance tecarfarin, a novel oral anticoagulant, through a pivotal Phase 3 trial (TECH-LVAD) for patients with Left Ventricular Assist Devices (LVADs). Abbott will support trial design, site identification, and provide expertise on the HeartMate 3(TM) LVAD, the only LVAD approved in the U.S. Tecarfarin has received FDA Orphan Drug Designation for preventing thromboembolism in LVAD patients, aiming to offer a safer and more effective alternative to warfarin.
In December 2024, Abbott Laboratories and DexCom have resolved all ongoing patent disputes concerning continuous glucose monitoring devices. The settlement includes the dismissal of all pending cases worldwide and a mutual commitment to refrain from future patent or appearance-related legal actions for the next decade.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.